Fractora RF Microneedling: Clinical Applications and Efficacy in Dermatologic Practice

Introduction

Fractora is an advanced fractional radiofrequency microneedling system manufactured by InMode that combines bipolar radiofrequency energy delivery through insulated microneedles to create controlled thermal injury zones in the dermis while preserving the epidermis. This technology represents a significant advancement in minimally invasive skin rejuvenation, offering efficacy comparable to more aggressive resurfacing techniques with reduced downtime and safety across diverse skin types.

Device Technology and Specifications

The Fractora system delivers bipolar radiofrequency energy through individual microneedles, with a unique feature that each needle carries its own energy source rather than relying on a single active needle with passive leads. This architecture allows for more uniform energy distribution and precise therapeutic control.

The device offers two primary needle tip configurations:

• 60-pin tip: Features variable depth from 0.6-1.0 mm, designed to stimulate the mid-dermis for textural improvements and addresses fine lines and surface irregularities
• 24-pin tip: Provides deeper penetration up to 3.0 mm, optimized for more substantial collagen remodeling and treatment of deeper scars

A distinctive feature of Fractora is the availability of silicone-coated needle tips on the 24-pin configuration. The silicone coating extends approximately two-thirds down the needle length, protecting the epidermis and superficial dermis from thermal injury while channeling energy into the deeper dermal structures. This allows clinicians to customize treatment depth and thermal profile based on specific clinical indications.

Energy settings range from 15-30 mJ per needle depending on the treatment area, desired depth, and indication. Adjustable depth parameters from 0.5-3.5 mm accommodate various anatomic sites and scar morphologies.

Mechanism of Action

Fractora operates through controlled selective thermal injury of dermal tissue. The insulated microneedles penetrate to predetermined depths, bypassing the epidermis to deliver radiofrequency energy at the needle tip and along the shaft. This creates microthermal zones that trigger robust collagen denaturation and neocollagenesis without the epidermal damage characteristic of traditional ablative resurfacing.

The mechanism involves two distinct processes: the microneedling channels create pathways for transepidermal water loss and enhanced product penetration, while the radiofrequency energy stimulates fibroblast activation and collagen remodeling. The combination produces superior results compared to microneedling alone, with tissue remodeling continuing for 3-6 months following treatment as newly synthesized collagen matures and remodels.

Clinical Indications

Atrophic Acne Scarring: Fractora demonstrates particular efficacy in treating boxcar and rolling acne scars. A 2025 prospective study using Fractora with energy settings of 15-30 mJ/pin delivered in 1-2 passes achieved statistically significant scar improvement. The device shows superior results in certain scar morphologies, with M-shaped rolling scars demonstrating the fastest response to treatment, while icepick scars require combination therapy for optimal outcomes.

Rhytides and Skin Laxity: Clinical studies evaluating combination therapy with bipolar radiofrequency (InMode FaceTite) and fractional bipolar radiofrequency (Fractora) demonstrated statistically significant improvement in Baker Face/Neck classification ratings in 100% of subjects, with 93% reporting subjective satisfaction with post-treatment improvement in facial laxity. Treatment effects include reduction of dynamic and static wrinkles with progressive improvement through 3-6 months post-treatment.

Hyperpigmentation: Fractora effectively addresses post-inflammatory hyperpigmentation and melasma through microneedling-induced injury triggering re-epithelialization with normalization of melanin deposition patterns. The controlled thermal injury does not produce additional pigmentary concerns in appropriate candidates.

Other Indications: Clinicians also utilize Fractora for treatment of active acne, seborrheic keratosis improvement, and as adjunctive therapy for hidradenitis suppurativa. Recent real-world data demonstrates clinical efficacy and safety across multiple anatomical sites in hidradenitis suppurativa patients with refractory disease.

Treatment Protocol

Optimal results require a series of 3-4 treatments spaced 4-6 weeks apart. The 4-6 week interval allows adequate time for collagen remodeling while minimizing cumulative thermal injury. Treatment sessions typically last 20-40 minutes depending on treatment area size and needle configuration selected.

Pre-treatment preparation includes thorough cleansing and application of topical anesthetic cream or local infiltration anesthesia. The 24-pin tip is generally better tolerated by patients given the smaller number of puncture sites, though clinicians should select configuration based on clinical indication rather than patient comfort alone.

Post-treatment immediate care involves cooling the treatment area and application of soothing serums. Most patients experience erythema lasting 1-3 days, with some degree of edema resolving within 48-72 hours. Patients should avoid strenuous exercise and excessive heat exposure for 5-7 days post-treatment.

Clinical Efficacy Comparative Data

Long-term follow-up studies comparing treatment modalities for acne scarring revealed significantly different relapse rates at 3-year follow-up: isotretinoin monotherapy 67%, laser treatment 75%, and fractional radiofrequency microneedling 24%. This dramatic difference highlights the sustained improvement and low relapse rate with RF microneedling technology.

Comparison to other radiofrequency microneedling devices shows important distinctions. While Morpheus8 achieves greater depth penetration (up to 4.0 mm versus Fractora's 3.0 mm maximum), making it superior for advanced scarring and significant skin laxity, Fractora provides excellent results for texture refinement, fine lines, and moderate scarring. The choice between devices should be individualized based on scar depth, treatment goals, and anatomic considerations.

Safety in Skin of Color

Radiofrequency microneedling demonstrates a favorable safety profile in darker skin types (Fitzpatrick IV-VI). A comprehensive review identifying 35 articles on RF or RFM use in skin of color found that RF and radiofrequency microneedling have a substantially lower risk of postprocedural dyspigmentation compared to conventional resurfacing modalities. Among the reviewed studies, only 7 noted transient post-inflammatory hyperpigmentation, 1 observed mild prolonged hyperpigmentation, and only 1 reported permanent scarring.

The mechanism underlying this safety advantage relates to the insulated needle design. Energy delivery occurs in the dermis without epidermal disruption, reducing inflammatory stimuli that trigger dyspigmentation in melanocyte-rich skin. Clinicians should still employ conservative energy settings and longer intervals between treatments in higher Fitzpatrick types, but Fractora can be safely offered to diverse patient populations.

Contraindications and Precautions

Absolute contraindications include active infection at the treatment site, malignancy in the target area, and severe dermatologic conditions during acute flares. Relative contraindications include recent isotretinoin use (within 6-12 months), active herpes simplex infection, pregnancy, and unrealistic patient expectations.

Caution is warranted in patients with a history of keloids, hypertrophic scarring, or significant dyspigmentation disorders. Patients on anticoagulants may experience increased bruising but this is not an absolute contraindication with appropriate precautions.

Adverse Events and Patient Safety

Fractora has an excellent safety profile with primarily transient adverse effects. Erythema and mild edema resolve within 3-5 days in most patients. Some patients experience temporary post-inflammatory hyperpigmentation that typically resolves within 2-4 weeks. Persistent post-inflammatory hyperpigmentation is rare when conservative energy settings are employed in higher Fitzpatrick skin types.

Permanent scarring is extremely rare with appropriate technique and patient selection. Infection risk is minimal with standard post-treatment wound care and patient education regarding hygiene and avoidance of contamination.

Integration with Medical Dermatology

Fractora works synergistically with topical and systemic acne therapies. Patients with active acne benefit from Fractora treatment combined with appropriate medical management, with the radiofrequency energy providing direct therapeutic benefit for active inflammatory lesions while mitigating post-inflammatory scarring risk. Incorporating Fractora into comprehensive acne management protocols can significantly improve long-term cosmetic outcomes.

Clinical Pearls

• Select needle configuration based on depth of pathology: 60-pin for superficial textural concerns, 24-pin for deeper scarring
• Utilize silicone-coated needles to protect epidermis when deep dermal penetration is desired with minimal surface disruption
• Space treatments 4-6 weeks apart to allow adequate collagen remodeling and minimize cumulative thermal injury
• Manage patient expectations regarding timeline, as maximal improvement continues 3-6 months post-final treatment
• Employ conservative energy settings in darker skin types with longer intervals between treatments
• Combine with appropriate medical therapies for optimal outcomes in acne-prone patients

References

• Rattananukrom T, et al. Efficacy of Microneedle Fractional Radiofrequency Combined With Topical Insulin for the Treatment of Facial Atrophic Acne Scars: A Split-Face, Double-Blinded, Randomized, Placebo-Controlled Trial. J Cosmet Dermatol. 2025;23(1).
• Safir JS, et al. Fractional Microneedling Radiofrequency for Hidradenitis Suppurativa: A Real-World Retrospective Study Demonstrating Clinical Efficacy and Safety Across Diverse Anatomical Sites. J Cosmet Dermatol. 2026;24(5).
• Morsi A, et al. The Role of Fractional Radiofrequency in Long-term Acne Remission and Reduction of Acne Scar Load. PLoS One. 2025;20(1).
• Gupta H, et al. Radiofrequency and Radiofrequency Microneedling in Skin of Color: A Review of Usage, Safety, and Efficacy. Dermatol Surg. 2023;49(5):547-556.
• Leibaschoff G. Fractional Radiofrequency Microneedling: Physics, Efficacy and Patient Selection. Facial Plast Surg Aesthet Med. 2022;24(3):165-172.
• Adatto MA, et al. Microneedle radiofrequency for skin rejuvenation: bridging image-derived metrics and photographic assessment. Front Med. 2025;12:1710949.
• Alster TS, et al. Transcutaneous Radiofrequency Microneedling in the Facial Plastic Surgeon's Practice: A Review. Facial Plast Surg Aesthet Med. 2023;25(2):89-98.
• Novak J, et al. Physics of fractional microneedle radiofrequency: A review. Lasers Surg Med. 2025;57(4):215-226.